Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae.
Pérez-Nadales E, Fernández-Ruiz M, Natera AM, Gutiérrez-Gutiérrez B, Mularoni A, Russelli G, Pierrotti LC, Pinheiro Freire M, Falcone M, Tiseo G, Tumbarello M, Raffaelli F, Abdala E, Bodro M, Gervasi E, Fariñas MC, Seminari EM, Castón JJ, Marín-Sanz JA, Gálvez-Soto V, Rana MM, Loeches B, Martín-Dávila P, Pascual Á, Rodríguez-Baño J, Aguado JM, Martínez-Martínez L, Torre-Cisneros J; REIPI/INCREMENT-SOT Study Group. Pérez-Nadales E, et al. Among authors: tumbarello m. Am J Transplant. 2023 Jul;23(7):1022-1034. doi: 10.1016/j.ajt.2023.03.011. Epub 2023 Apr 5. Am J Transplant. 2023. PMID: 37028515 Free article.
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study).
Bassetti M, Vena A, Giacobbe DR, Falcone M, Tiseo G, Giannella M, Pascale R, Meschiari M, Digaetano M, Oliva A, Rovelli C, Carannante N, Losito AR, Carbonara S, Mariani MF, Mastroianni A, Angarano G, Tumbarello M, Tascini C, Grossi P, Mastroianni CM, Mussini C, Viale P, Menichetti F, Viscoli C, Russo A; CEFTABUSE Study Group. Bassetti M, et al. Among authors: tumbarello m. Open Forum Infect Dis. 2020 Apr 21;7(5):ofaa139. doi: 10.1093/ofid/ofaa139. eCollection 2020 May. Open Forum Infect Dis. 2020. PMID: 32462046 Free PMC article.
PRESTIGIO RING "a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests".
Panza F, Saladini F, Bartolini N, Gianmarino F, Montagnani F, Spagnuolo V, Tumbarello M, Santoro MM, Castagna A, Zazzi M, Fabbiani M. Panza F, et al. Among authors: tumbarello m. New Microbiol. 2024 May;47(1):116-122. New Microbiol. 2024. PMID: 38700893 Free article.
Meropenem-vaborbactam as intrathecal-sparing therapy for the treatment of carbapenem-resistant K. pneumoniae shunt-related ventriculitis: two case reports and review of the literature.
Giuliano G, Sambo M, Castellani P, Benedetti S, Tarantino F, Tumbarello M. Giuliano G, et al. Among authors: tumbarello m. Eur J Clin Microbiol Infect Dis. 2025 Jan;44(1):193-196. doi: 10.1007/s10096-024-04986-6. Epub 2024 Nov 12. Eur J Clin Microbiol Infect Dis. 2025. PMID: 39531123 Review.
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV.
Polvere J, Fabbiani M, Pastore G, Rancan I, Rossetti B, Durante M, Zirpoli S, Morelli E, Pettini E, Lucchesi S, Fiorino F, Tumbarello M, Ciabattini A, Montagnani F, Medaglini D. Polvere J, et al. Among authors: tumbarello m. Commun Med (Lond). 2023 Jan 30;3(1):13. doi: 10.1038/s43856-023-00245-5. Commun Med (Lond). 2023. PMID: 36717688 Free PMC article.
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant.
Pastore G, Polvere J, Fiorino F, Lucchesi S, Montesi G, Rancan I, Zirpoli S, Lippi A, Durante M, Fabbiani M, Tumbarello M, Montagnani F, Medaglini D, Ciabattini A. Pastore G, et al. Among authors: tumbarello m. Expert Rev Vaccines. 2024 Jan-Dec;23(1):432-444. doi: 10.1080/14760584.2024.2333952. Epub 2024 Apr 2. Expert Rev Vaccines. 2024. PMID: 38517153 Free article.
Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses.
Paciello I, Pierleoni G, Pantano E, Antonelli G, Pileri P, Maccari G, Cardamone D, Realini G, Perrone F, Neto MM, Pozzessere S, Fabbiani M, Panza F, Rancan I, Tumbarello M, Montagnani F, Medini D, Maes P, Temperton N, Simon-Loriere E, Schwartz O, Rappuoli R, Andreano E. Paciello I, et al. Among authors: tumbarello m. Cell Rep. 2024 Sep 24;43(9):114645. doi: 10.1016/j.celrep.2024.114645. Epub 2024 Aug 27. Cell Rep. 2024. PMID: 39207904 Free PMC article.
303 results